To determine if treatment with a combined therapeutic regimen, which resulted in clinical benefit in a subset of patients in a clinical trial, alters miRNA expression in a way that may be used to guid
miRNA expression in lung fibroblasts by Nanostring analysis. Healthy control lung fibroblasts (HC) and SSc-ILD lung fibroblasts were stimulated with media, interleukin-13 (IL-13), interferon alpha (IF
